These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Certification of suitability of monographs of the European pharmacopoeia]. Artiges A Ann Pharm Fr; 2002 Sep; 60(5):333-40. PubMed ID: 12378143 [TBL] [Abstract][Full Text] [Related]
43. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Twenty-fourth report. World Health Organ Tech Rep Ser; 1972; 487():1-86. PubMed ID: 4623961 [No Abstract] [Full Text] [Related]
44. Reduction of animal usage: British Pharmacopoeia Commission policy. Rabouhans ML Dev Biol Stand; 1986; 64():11-6. PubMed ID: 3792640 [TBL] [Abstract][Full Text] [Related]
45. [Role of the Pharmacopoeia Committee of the Ministry of Public Health of the USSR in improving drug preparation quality]. Oboĭmakova OM Farm Zh; 1977; 32(4):28-31. PubMed ID: 913542 [No Abstract] [Full Text] [Related]
46. [Pharmacopoeia standard samples (standards)]. Arzamastsev AP Farmatsiia; 1968; 17(2):78-81. PubMed ID: 4887050 [No Abstract] [Full Text] [Related]
47. Role and functions of the Nordic Pharmacopoeia. Fors M Ann Ist Super Sanita; 1975; 11(3-4):220-7. PubMed ID: 1234724 [TBL] [Abstract][Full Text] [Related]
48. Regulatory aspects of drug dissolution from a European perspective. Graffner C Eur J Pharm Sci; 2006 Nov; 29(3-4):288-93. PubMed ID: 16950606 [TBL] [Abstract][Full Text] [Related]
49. [The 10th edition of the USSR Government Pharmacopoeia as a standard for medicinal plant raw material]. Linchenko NA Farmatsiia; 1969; 18(6):5-8. PubMed ID: 5383454 [No Abstract] [Full Text] [Related]
50. Biological standards and pharmacopoeias. Perkins FT Ann Ist Super Sanita; 1975; 11(3-4):322-32. PubMed ID: 1234734 [TBL] [Abstract][Full Text] [Related]
51. [Technical implications on the quality standard of new drugs]. Uchiyama M Eisei Shikenjo Hokoku; 1995; (113):135-6. PubMed ID: 8717247 [TBL] [Abstract][Full Text] [Related]
52. The diminishing value of the Physicians' Desk Reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs. Burkhart CG J Drugs Dermatol; 2005; 4(4):414-5. PubMed ID: 16004013 [No Abstract] [Full Text] [Related]
53. [Collaborative study of Japanese Pharmacopoeia Heparin Sodium Reference Standard (Control 871)]. Yomota C; Hasegawa R; Komuro T; Okada S; Kimura T Eisei Shikenjo Hokoku; 1989; (107):148-51. PubMed ID: 2636920 [TBL] [Abstract][Full Text] [Related]
54. [Microbiologic purity of drugs. Directions and methods for a pharmacopoeia]. Bühlmann X; Gay M; Gubler HU; Hess H; Kabay A; Knüsel F; Sackmann W; Schiller I; Urban S Pharm Acta Helv; 1971 Jun; 46(6):321-50. PubMed ID: 4934777 [No Abstract] [Full Text] [Related]
56. [Quality control in the pharmaceutical industry]. Bretscher E Pharm Acta Helv; 1972; 47(11):664-75. PubMed ID: 4657535 [No Abstract] [Full Text] [Related]
57. Composition specification of teicoplanin based on its estimated relative bioavailability. Boix-Montañes A; Garcia-Arieta A Drug Dev Ind Pharm; 2015 Feb; 41(2):218-23. PubMed ID: 24506456 [TBL] [Abstract][Full Text] [Related]
58. [Implementation of the Latest Scientific Knowledge/Technologies and Activities for International Harmonisation of the Japanese Pharmacopoeia]. Ando T; Osawa T Yakugaku Zasshi; 2020; 140(6):763-766. PubMed ID: 32475924 [TBL] [Abstract][Full Text] [Related]
59. Pharmacopeial standards and specifications for bulk drugs and solid oral dosage forms. Similarities and differences. French WN; Matsui F; Cook D; Levi L J Pharm Sci; 1967 Dec; 56(12):1622-41. PubMed ID: 5588715 [No Abstract] [Full Text] [Related]
60. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report. WHO Expert Committee on Specifications for Pharmaceutical Preparations World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]